Imuraya Group Company Limited operates within the Candy & other confectionery products sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Imuraya Group Company Limited with three other
bakery and confectionary companies in Asia:
Ismail Industries Limited
sales of 17.01 billion Pakistan Rupees [US$162.26 million]
GlaxoSmithKline Consumer Healthcare Limited
(43.09 billion Indian Rupees [US$631.66 million]
of which 100%
was Nutritionals), and
Nakamuraya Co., Ltd.
(41.37 billion Japanese Yen [US$360.73 million]
of which 70%
was Confectionery Business).
During the year ended March of 2016, sales at
Imuraya Group Company Limited were ¥38.64 billion (US$336.98 million).
increase of 6.3%
versus 2015, when the company's sales were ¥36.35 billion.
This was the fifth consecutive year of sales increases at Imuraya Group Company Limited
(and since 2011, sales have increased a total of 21%).
Sales of Other Businesses saw an increase
10.1% in 2016, from
¥211.59 million to ¥232.89 million.